Filing Details

Accession Number:
0001104659-21-030172
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-01 17:39:56
Reporting Period:
2021-02-25
Accepted Time:
2021-03-01 17:39:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1609550 Inspire Medical Systems Inc. INSP Surgical & Medical Instruments & Apparatus (3841) 261377674
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1737133 Richard Buchholz C/O Inspire Medical Systems, Inc.
5500 Wayzata Blvd., Suite 1600
Golden Valley MN 55416
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-02-25 700 $223.74 65,069 No 4 S Direct
Common Stock Disposition 2021-02-25 5,682 $224.78 59,387 No 4 S Direct
Common Stock Disposition 2021-02-25 7,817 $225.74 51,570 No 4 S Direct
Common Stock Disposition 2021-02-25 4,401 $226.68 47,169 No 4 S Direct
Common Stock Disposition 2021-02-25 1,000 $227.44 46,169 No 4 S Direct
Common Stock Disposition 2021-02-25 400 $228.30 45,769 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 880 Indirect By Daughter
Common Stock 880 Indirect By Son
Common Stock 880 Indirect By Son
Common Stock 880 Indirect By Son
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.13 to $224.10. The reporting person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. Includes 118 shares acquired under the Company's 2018 Employee Stock Purchase Plan since the date of the reporting person's last ownership report.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.14 to $225.11. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.14 to $226.12. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $226.16 to $227.13. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $227.18 to $228.00. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $228.18 to $228.49. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.